The ownership structure of Biodexa Pharmaceuticals (BDRX) stock is a mix of institutional, retail and individual investors. Approximately 19.76% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 80.24% is owned by Public Companies and Individual Investors.
The ownership structure of Biodexa Pharmaceuticals (BDRX) stock is a mix of institutional, retail and individual investors. Approximately 19.76% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 80.24% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder
# of Shares
Type
% Holding
Value
1,957
Institution
0.75%
569
Top Mutual Fund Holders
Holder
# of Shares
Type
% Holding
Value
1,957
Institution
0.75%
569
Top ETF Holders
Holder
# of Shares
Type
% Holding
Value
FAQ
Who Owns Biodexa Pharmaceuticals (BDRX)?
According to the latest TipRanks data, approximately 19.02% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 80.24% is held by retail investors.
What percentage of Biodexa Pharmaceuticals (BDRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.02% of Biodexa Pharmaceuticals (BDRX) stock is held by institutional investors.
What percentage of Biodexa Pharmaceuticals (BDRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 80.24% of Biodexa Pharmaceuticals (BDRX) stock is held by retail investors.
Who owns the most shares of Biodexa Pharmaceuticals (BDRX)?
Fidelity Concord Street Trust owns the most shares of Biodexa Pharmaceuticals (BDRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.